Drugs / D-CIK
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02651441 | Feb 2016 → May 2019 | non-small cell lung carcinoma | Shenzhen Hornetcorn Bio-technology Company, LTD | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D-CIK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02651441 ↗ |
| Modality | Cell therapy | “dendritic activated cytokine-induced killer cell (D-CIK)” NCT02651441 ↗ |